Season 1, Episode 1
Smart KPIs for Biotechs
Sabine Hutchison and Alan Morgan discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Listen to the full episode right now!
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Alan Morgan is an experienced leader in pharmaceutical services, having operated in C suite roles for 25 years. He is an advisor and consultant within Private Equity, a non-executive advisor to Excelya in Paris, non-executive chairman of Gentronix Limited (a genetic toxicology early stage CRO PE backed), and an advisor to Luure.ai , a US based AI tech startup.
Join the discussion and listen to the full episode here.
Related Episodes
S2 E3 – Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
Season 2, Episode 3 Transforming Clinical Trials: How Digital Endpoints Are Leading the WayIn the third episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by Victoria Bangieva from the Digital Medicine Society (DiMe) and our very own...
S2 E2 – Navigating the Commercialization Journey: Insights from Science to Market
Season 2, Episode 2 Navigating the Commercialization Journey: Insights from Science to MarketIn the second episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the dynamic Kirsten Detrick, whose extensive experience in biotech and pharma...
0 Comments